28.8 C
New York
Sunday, June 14, 2026

Tag: CHN ASA

Divamics’ AI and Molecular Dynamics Platform Powers Breakthroughs in Metabolic Disease Drug Discovery for Partners

SUZHOU, China, July 14, 2025 /PRNewswire/ -- Divamics, a pioneer in AI-driven drug discovery, highlighted its critical role in advancing metabolic disease therapeutics through...

Concord Healthcare Announces Completion of China’s First Proton Therapy for Choroidal Malignant Melanoma

BEIJING, July 14, 2025 /PRNewswire/ -- Concord Healthcare Group Co., Ltd. ("Concord Healthcare"), a subsidiary of Concord Medical Services Holdings Limited (the "Company") (NYSE: CCM),...

Zoomlion Accelerates Global Expansion with Intensive Multi-Line Deliveries for Major International Construction Projects

CHANGSHA, China, July 14, 2025 /PRNewswire/ -- Zoomlion Heavy Industry Science & Technology Co., Ltd. ("Zoomlion", 1157.HK) has recently completed a series of intensive...

Mouser Electronics New Product Insider: Over 15,000 New Parts Added in Second Quarter of 2025

SHANGHAI, July 11, 2025 /PRNewswire/ -- Mouser Electronics, Inc., As an authorized distributor, Mouser Electronics, Inc. is focused on the rapid introduction of new electronic...

WuXi AppTec Issues Positive Profit Alert for the First Half of 2025

SHANGHAI, July 10, 2025 /PRNewswire/ -- WuXi AppTec Co., Ltd. (stock code: 603259.SH/2359.HK), a leading global pharmaceutical and life sciences technology platform company offering...

HIKMICRO Expands into Global Instrumentation Market

HANGZHOU, China, July 10, 2025 /PRNewswire/ -- HIKMICRO, a subsidiary of HIKVISION has formally entered the global instrumentation market with the introduction of high-precision Coriolis...

VSA Regains Compliance with Nasdaq Minimum Bid Price Requirement

BEIJING, July 9, 2025 /PRNewswire/ -- TCTM Kids IT Education Inc. (NASDAQ: VSA) ("VSA" or the "Company"), an emerging technology services company, specializing in...

Global Times: Xi stresses transforming resource-based economy in Shanxi inspection tour

BEIJING, July 9, 2025 /PRNewswire/ -- President Xi Jinping has called on North China's Shanxi Province to further promote the transformation and development of the...

First Patient Dosed in Phase 1/2 Clinical Study of Novel EGFR/HER3 Bispecific Antibody-Drug Conjugate AVZO-1418/DB-1418

SHANGHAI, July 9, 2025 /PRNewswire/ -- Duality Biotherapeutics' ("DualityBio", HKEX:09606) partner Avenzo Therapeutics, Inc. ("Avenzo"), a clinical-stage biotechnology company developing next-generation oncology therapies, today...

First Patient Dosed in Phase 1/2 Clinical Study of Novel EGFR/HER3 Bispecific Antibody-Drug Conjugate AVZO-1418/DB-1418

SHANGHAI, July 8, 2025 /PRNewswire/ -- Duality Biotherapeutics' ("DualityBio", HKEX:09606) partner Avenzo Therapeutics, Inc. ("Avenzo"), a clinical-stage biotechnology company developing next-generation oncology therapies, today...

6 Commercial Garage Doors That Are Keeping Businesses on Schedule

SHANGHAI, July 8, 2025 /PRNewswire/ -- After a third delivery truck got stuck outside a busy warehouse due to another garage door failure, the...

Hi & Fi Asia-China 2025 Shatters Records: Global Engagement Soars

SHANGHAI, July 8, 2025 /PRNewswire/ -- The 2025 edition of Hi & Fi Asia-China, held from24-26 June at NECC, Shanghai, concluded as its most impactful...

World Premiere of the “Quintet of Liangzhu Civilization” Animated Shorts on Liangzhu Day

HANGZHOU, China, July 7, 2025 /PRNewswire/ -- The annual "Hangzhou Liangzhu Day" returned on July 6, 2025! On July 7, a new animated short...

Global Times: ‘Our pursuit of modern economic development must be underpinned by strategic foresight and holistic coordination’

BEIJING, July 4, 2025 /PRNewswire/ -- More than 30 years ago, while working in Xiamen, East China's Fujian Province, Xi Jinping led the formulation of...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCHN ASA